290 related articles for article (PubMed ID: 16704888)
1. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu.
Salem ML; El-Naggar SA; Kadima A; Gillanders WE; Cole DJ
Vaccine; 2006 Jun; 24(24):5119-32. PubMed ID: 16704888
[TBL] [Abstract][Full Text] [Related]
2. Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity.
Salem ML; Kadima AN; Cole DJ; Gillanders WE
J Immunother; 2005; 28(3):220-8. PubMed ID: 15838378
[TBL] [Abstract][Full Text] [Related]
3. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta.
Ngoi SM; Tovey MG; Vella AT
J Immunol; 2008 Dec; 181(11):7670-80. PubMed ID: 19017955
[TBL] [Abstract][Full Text] [Related]
4. The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice.
Salem ML; Diaz-Montero CM; El-Naggar SA; Chen Y; Moussa O; Cole DJ
Vaccine; 2009 Jan; 27(4):549-57. PubMed ID: 19027047
[TBL] [Abstract][Full Text] [Related]
5. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
6. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
[TBL] [Abstract][Full Text] [Related]
7. Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method.
Nordly P; Rose F; Christensen D; Nielsen HM; Andersen P; Agger EM; Foged C
J Control Release; 2011 Mar; 150(3):307-17. PubMed ID: 21111765
[TBL] [Abstract][Full Text] [Related]
8. Diesel exhaust particles suppress in vivo IFN-gamma production by inhibiting cytokine effects on NK and NKT cells.
Finkelman FD; Yang M; Orekhova T; Clyne E; Bernstein J; Whitekus M; Diaz-Sanchez D; Morris SC
J Immunol; 2004 Mar; 172(6):3808-13. PubMed ID: 15004186
[TBL] [Abstract][Full Text] [Related]
9. Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta.
Plett A; Murasko DM
Mech Ageing Dev; 2000 Jan; 112(3):197-215. PubMed ID: 10687925
[TBL] [Abstract][Full Text] [Related]
10. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.
Schmidt KN; Leung B; Kwong M; Zarember KA; Satyal S; Navas TA; Wang F; Godowski PJ
J Immunol; 2004 Jan; 172(1):138-43. PubMed ID: 14688319
[TBL] [Abstract][Full Text] [Related]
11. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
[TBL] [Abstract][Full Text] [Related]
12. The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice.
Salem ML; El-Naggar SA; Mobasher MA; Elgharabawy RM
J Immunol Res; 2020; 2020():2489407. PubMed ID: 32211442
[TBL] [Abstract][Full Text] [Related]
13. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
14. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection.
Salazar-Mather TP; Ishikawa R; Biron CA
J Immunol; 1996 Oct; 157(7):3054-64. PubMed ID: 8816415
[TBL] [Abstract][Full Text] [Related]
15. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM
J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice.
Su HC; Ishikawa R; Biron CA
J Immunol; 1993 Nov; 151(9):4874-90. PubMed ID: 8409446
[TBL] [Abstract][Full Text] [Related]
17. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
18. Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors.
Qiu F; Maniar A; Diaz MQ; Chapoval AI; Medvedev AE
Innate Immun; 2011 Aug; 17(4):375-87. PubMed ID: 20682587
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2-induced proliferation of murine natural killer cells in vivo.
Biron CA; Young HA; Kasaian MT
J Exp Med; 1990 Jan; 171(1):173-88. PubMed ID: 1688606
[TBL] [Abstract][Full Text] [Related]
20. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
